Cargando…

Frequent Activation of Notch Signaling Pathway in Colorectal Cancers and Its Implication in Patient Survival Outcome

Colorectal cancer is a major health concern as it ranks third in incidence and second major cause of cancer-related deaths worldwide. A leading cause of treatment failure has been attributed to cancer stem cells that can invariably resist existing chemotherapeutic regimens. Notch signaling pathway h...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaik, Jilani Purusottapatnam, Alanazi, Ibrahim O., Pathan, Akbar Ali Khan, Parine, Narasimha Reddy, Almadi, Majid A., Azzam, Nahla A., Aljebreen, Abdulrahman M., Alharbi, Othman, Alanazi, Mohammad Saud, Khan, Zahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085396/
https://www.ncbi.nlm.nih.gov/pubmed/32211044
http://dx.doi.org/10.1155/2020/6768942
_version_ 1783508936183250944
author Shaik, Jilani Purusottapatnam
Alanazi, Ibrahim O.
Pathan, Akbar Ali Khan
Parine, Narasimha Reddy
Almadi, Majid A.
Azzam, Nahla A.
Aljebreen, Abdulrahman M.
Alharbi, Othman
Alanazi, Mohammad Saud
Khan, Zahid
author_facet Shaik, Jilani Purusottapatnam
Alanazi, Ibrahim O.
Pathan, Akbar Ali Khan
Parine, Narasimha Reddy
Almadi, Majid A.
Azzam, Nahla A.
Aljebreen, Abdulrahman M.
Alharbi, Othman
Alanazi, Mohammad Saud
Khan, Zahid
author_sort Shaik, Jilani Purusottapatnam
collection PubMed
description Colorectal cancer is a major health concern as it ranks third in incidence and second major cause of cancer-related deaths worldwide. A leading cause of treatment failure has been attributed to cancer stem cells that can invariably resist existing chemotherapeutic regimens. Notch signaling pathway has been involved in the maintenance of stem cells besides being crucial in cell fate decision and embryonic development. This pathway has also been implicated in several human malignancies including colorectal cancer. We investigated mRNA expression of four Notch receptors (Notch1–4), five ligands (Jag1, Jag2, Dll1, Dll3, and Dll4), and four target genes (Hes1, Hes5, Hey1, and Hey2) using highly specific TaqMan gene expression assays in colorectal adenomas and cancers. Upregulated expression of Notch receptors ranged between 29 and 73% in colorectal cancers and between 11 and 56% in adenomas. Expression of Notch3 and Notch4 receptors was significantly higher in colorectal cancers compared to normal and adenoma tissues. The Jagged and Delta-like ligands were overexpressed between 25 and 52% in colorectal cancers, while in adenomas, it ranged between 0 and 33%. Combining the data for upregulation of receptors and ligands suggests that 86% colorectal cancers and 56% adenomas exhibited overexpression of Notch pathway genes in our cohort. Notch target genes were upregulated between 24 and 33% in colorectal cancers and between 11 and 22% in adenomas. Collating upregulation of Notch receptors and ligands with the target genes showed concordance in 58% colorectal tumors. Additionally, we evaluated expression of Notch receptors, ligands, and target genes with prognosis using the TCGA mRNA expression dataset. Patients overexpressing Notch3, Notch4, and Hey1 had significantly poorer overall survival relative to those having lower levels of these genes. Taken together, Notch signaling components are aberrantly overexpressed in colorectal tumors, and development of therapeutics targeting the Notch pathway may prove to be beneficial in the management of colorectal cancers.
format Online
Article
Text
id pubmed-7085396
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-70853962020-03-24 Frequent Activation of Notch Signaling Pathway in Colorectal Cancers and Its Implication in Patient Survival Outcome Shaik, Jilani Purusottapatnam Alanazi, Ibrahim O. Pathan, Akbar Ali Khan Parine, Narasimha Reddy Almadi, Majid A. Azzam, Nahla A. Aljebreen, Abdulrahman M. Alharbi, Othman Alanazi, Mohammad Saud Khan, Zahid J Oncol Research Article Colorectal cancer is a major health concern as it ranks third in incidence and second major cause of cancer-related deaths worldwide. A leading cause of treatment failure has been attributed to cancer stem cells that can invariably resist existing chemotherapeutic regimens. Notch signaling pathway has been involved in the maintenance of stem cells besides being crucial in cell fate decision and embryonic development. This pathway has also been implicated in several human malignancies including colorectal cancer. We investigated mRNA expression of four Notch receptors (Notch1–4), five ligands (Jag1, Jag2, Dll1, Dll3, and Dll4), and four target genes (Hes1, Hes5, Hey1, and Hey2) using highly specific TaqMan gene expression assays in colorectal adenomas and cancers. Upregulated expression of Notch receptors ranged between 29 and 73% in colorectal cancers and between 11 and 56% in adenomas. Expression of Notch3 and Notch4 receptors was significantly higher in colorectal cancers compared to normal and adenoma tissues. The Jagged and Delta-like ligands were overexpressed between 25 and 52% in colorectal cancers, while in adenomas, it ranged between 0 and 33%. Combining the data for upregulation of receptors and ligands suggests that 86% colorectal cancers and 56% adenomas exhibited overexpression of Notch pathway genes in our cohort. Notch target genes were upregulated between 24 and 33% in colorectal cancers and between 11 and 22% in adenomas. Collating upregulation of Notch receptors and ligands with the target genes showed concordance in 58% colorectal tumors. Additionally, we evaluated expression of Notch receptors, ligands, and target genes with prognosis using the TCGA mRNA expression dataset. Patients overexpressing Notch3, Notch4, and Hey1 had significantly poorer overall survival relative to those having lower levels of these genes. Taken together, Notch signaling components are aberrantly overexpressed in colorectal tumors, and development of therapeutics targeting the Notch pathway may prove to be beneficial in the management of colorectal cancers. Hindawi 2020-03-09 /pmc/articles/PMC7085396/ /pubmed/32211044 http://dx.doi.org/10.1155/2020/6768942 Text en Copyright © 2020 Jilani Purusottapatnam Shaik et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shaik, Jilani Purusottapatnam
Alanazi, Ibrahim O.
Pathan, Akbar Ali Khan
Parine, Narasimha Reddy
Almadi, Majid A.
Azzam, Nahla A.
Aljebreen, Abdulrahman M.
Alharbi, Othman
Alanazi, Mohammad Saud
Khan, Zahid
Frequent Activation of Notch Signaling Pathway in Colorectal Cancers and Its Implication in Patient Survival Outcome
title Frequent Activation of Notch Signaling Pathway in Colorectal Cancers and Its Implication in Patient Survival Outcome
title_full Frequent Activation of Notch Signaling Pathway in Colorectal Cancers and Its Implication in Patient Survival Outcome
title_fullStr Frequent Activation of Notch Signaling Pathway in Colorectal Cancers and Its Implication in Patient Survival Outcome
title_full_unstemmed Frequent Activation of Notch Signaling Pathway in Colorectal Cancers and Its Implication in Patient Survival Outcome
title_short Frequent Activation of Notch Signaling Pathway in Colorectal Cancers and Its Implication in Patient Survival Outcome
title_sort frequent activation of notch signaling pathway in colorectal cancers and its implication in patient survival outcome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085396/
https://www.ncbi.nlm.nih.gov/pubmed/32211044
http://dx.doi.org/10.1155/2020/6768942
work_keys_str_mv AT shaikjilanipurusottapatnam frequentactivationofnotchsignalingpathwayincolorectalcancersanditsimplicationinpatientsurvivaloutcome
AT alanaziibrahimo frequentactivationofnotchsignalingpathwayincolorectalcancersanditsimplicationinpatientsurvivaloutcome
AT pathanakbaralikhan frequentactivationofnotchsignalingpathwayincolorectalcancersanditsimplicationinpatientsurvivaloutcome
AT parinenarasimhareddy frequentactivationofnotchsignalingpathwayincolorectalcancersanditsimplicationinpatientsurvivaloutcome
AT almadimajida frequentactivationofnotchsignalingpathwayincolorectalcancersanditsimplicationinpatientsurvivaloutcome
AT azzamnahlaa frequentactivationofnotchsignalingpathwayincolorectalcancersanditsimplicationinpatientsurvivaloutcome
AT aljebreenabdulrahmanm frequentactivationofnotchsignalingpathwayincolorectalcancersanditsimplicationinpatientsurvivaloutcome
AT alharbiothman frequentactivationofnotchsignalingpathwayincolorectalcancersanditsimplicationinpatientsurvivaloutcome
AT alanazimohammadsaud frequentactivationofnotchsignalingpathwayincolorectalcancersanditsimplicationinpatientsurvivaloutcome
AT khanzahid frequentactivationofnotchsignalingpathwayincolorectalcancersanditsimplicationinpatientsurvivaloutcome